The Diagnostic Performance of the Visitect Advanced Disease Point-Of-Care CD4 Platform: A Pragmatic, Mixed-Methods, Multisite Validation, Costing, and Qualitative Analysis
Given variable specificity of the Visitect CD4 Advanced Disease platform, successful implementation will require consideration of clinic context and laboratory staffing.
Authors
- Ann Fieberg
- Elizabeth Nalintya
- Alice Lehman (ORCID: https://orcid.org/0000-0003-4690-784X)
- Mathius Amperiize (ORCID: https://orcid.org/0000-0002-4104-4830)
- David R. Boulware (ORCID: https://orcid.org/0000-0002-4715-0060)
- Richard Kwizera (ORCID: https://orcid.org/0000-0002-5270-3539)
- Paul Kavuma (ORCID: https://orcid.org/0000-0002-9363-0364)
- Biyue Dai (ORCID: https://orcid.org/0000-0002-4747-3687)
- Lucy Apeduno
- Preethiya Sekar
- Radha Rajasingham (ORCID: https://orcid.org/0000-0001-5531-0231)
- Patricia Nerima
- Olive Loryndah Namakula
- David B. Meya
- Viola Kasone
- Diana Rose Naluyima
- Rachel Nanano
- Lilian Mujungu
- Kiiza Kandole Tadeo
- Tessa Adzemovic
Institutions
- University of Minnesota (US)
- University of Minnesota System (US)
- Ministry of Health (UG)
- Infectious Diseases Institute (UG)
- University of Minnesota Medical Center (US)
- Makerere University (UG)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1097/qai.0000000000003505
- Citations
- 10
- Primary Topic
- Telemedicine and Telehealth Implementation
- Type
- article
- Field-Weighted Citation Impact
- 5.43
Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center